Skip to main content
SpringerLink
Log in

Hypoadiponectinemia: A common basis for diseases associated with overnutrition

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Adiponectin is a plasma protein derived from adipose tissue, which we discovered from a human adipose cDNA project. Adiponectin exists in circulating plasma at concentrations ranging from 4 to 30 µg/mL, which is much higher than the concentrations of various other hormones and cytokines. Adiponectin has a sticky nature, binding to collagen I, III, and V, which are present in vascular intima. Adiponectin exhibits various antiatherogenic effects on vascular cells, suppressing the expression of adhesion molecules in vascular endothelial cells, proliferation of smooth muscle cells, and cholesteryl-ester accumulation in macrophages. However, its plasma levels are low in subjects with excess intra-abdominal fat. Adiponectin also has antidiabetic properties, and plasma adiponectin levels correlate positively with insulin sensitivity. Several clinical studies have demonstrated that hypoadiponectinemia is a risk factor for new-onset diabetes. Recent studies suggest that hypoadiponectinemia may partly contribute to the development of salt-sensitive hypertension and hypertensive heart failure, and can be also a risk factor for overnutrition-related cancers such as breast, colon, uterine, and prostate cancers. Hypoadiponectinemia might be at least in part the molecular basis of various diseases associated with overnutrition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/Metabolic_syndrome_definition.pdf. Accessed May 12, 2006.

  2. Kissebah AH, Vydelingum N, Murray R, et al.: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982, 54:254–260.

    Article  PubMed  CAS  Google Scholar 

  3. Larsson B, Svardsudd K, Welin L, et al.: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J Clin Res Ed 1984, 288:1401–1404.

    Article  PubMed  CAS  Google Scholar 

  4. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S: Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987, 36:54–59.

    Article  PubMed  CAS  Google Scholar 

  5. Nakamura T, Tokunaga K, Shimomura I, et al.: Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994, 107:239–246.

    Article  PubMed  CAS  Google Scholar 

  6. Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989, 149:1514–1520.

    Article  PubMed  CAS  Google Scholar 

  7. Funahashi T, Nakamura T, Shimomura I, et al.: Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999, 38:202–206.

    Article  PubMed  CAS  Google Scholar 

  8. Maeda K, Okubo K, Shimomura I, et al.: cDNA cloning and expression of a novel adipose specific collagen-like factor, apMa (Adipose Most Abundant gene transcript 1). Biochem Biophys Res Commun 1996, 221: 286–289.

    Article  PubMed  CAS  Google Scholar 

  9. Arita Y, Kihara S, Ouchi N, et al.: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79–83.

    Article  PubMed  CAS  Google Scholar 

  10. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease? Diabetes 1988, 37:1595–1607.

    Article  PubMed  CAS  Google Scholar 

  11. Maeda K, Okubo K, Shimomura I, et al.: Analysis of an expression profile of genes in the human adipose tissue. Gene 1997, 190:227–235.

    Article  PubMed  CAS  Google Scholar 

  12. Shimomura I, Funahashi T, Takahashi M, et al.: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996, 2:800–803.

    Article  PubMed  CAS  Google Scholar 

  13. Ryo M, Nakamura T, Kihara S, et al.: Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68:975–981.

    Article  PubMed  CAS  Google Scholar 

  14. Okamoto Y, Arita Y, Nishida M, et al.: An adipocytederived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000, 32:47–50.

    Article  PubMed  CAS  Google Scholar 

  15. Ouchi N, Kihara S, Arita Y, et al.: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein, adiponectin. Circulation 1999, 100:2473–2476.

    PubMed  CAS  Google Scholar 

  16. Ouchi N, Kihara S, Arita Y, et al.: Adiponectin, adipocyte-derived plasma protein, inhibits endothelial NF-kB signaling through cAMP-dependent pathway. Circulation 2000, 102:1296–301.

    PubMed  CAS  Google Scholar 

  17. Arita Y, Kihara S, Ouchi N, et al.: Adipocyte-derived plasma protein, adiponectin, acts as a platelets growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002, 105:2893–2898.

    Article  PubMed  CAS  Google Scholar 

  18. Ouchi N, Kihara S, Arita Y, et al.: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001, 103:1057–1063.

    PubMed  CAS  Google Scholar 

  19. Matsuda M, Shimomura I, Sata M, et al.: Role of adiponectin in preventing vascular stenosis—the missing link of adipo-vascular axis. J Biol Chem 2002, 277:37487–37491.

    Article  PubMed  CAS  Google Scholar 

  20. Okamoto Y, Kihara S, Ouchi N, et al.: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106:2767–2770.

    Article  PubMed  CAS  Google Scholar 

  21. Weyer C, Funahashi T, Tanaka S, et al.: Hypoadiponectinemia in obesity and type 2 diabetes: Evidence for a role of insulin resistance and/or hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930–1935.

    Article  PubMed  CAS  Google Scholar 

  22. Hotta K, Funahashi T, Bodkin NL, et al.: Circulating concentrations of the adipocyte protein, adiponectin, are decreased in parallel with reduced insulin sensitivity during the progression to type-2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126–1133.

    Article  PubMed  CAS  Google Scholar 

  23. Maeda N, Shimomura I, Kishida K, et al.: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002, 8:731–737.

    Article  PubMed  CAS  Google Scholar 

  24. Lindsay RS, Funahashi T, Hanson RL, et al.: Adiponectin protects against development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57–58.

    Article  PubMed  CAS  Google Scholar 

  25. Ouchi N, Ohishi M, Kihara S, et al.: Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003, 42:231–234.

    Article  PubMed  CAS  Google Scholar 

  26. Ouchi N, Kobayashi H, Kihara S, et al.: Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004, 279:1304–1309.

    Article  PubMed  CAS  Google Scholar 

  27. Chen H, Montagnani M, Funahashi T, et al.: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003, 278:45021–45026.

    Article  PubMed  CAS  Google Scholar 

  28. Iwashima Y, Katsuya T, Ishikawa K, et al.: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004, 43:1318–1323.

    Article  PubMed  CAS  Google Scholar 

  29. Ohashi K, Kihara S, Ouchi N, et al.: Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006, 47:1108–1116.

    Article  PubMed  CAS  Google Scholar 

  30. Shibata R, Ouchi N, Ito M, et al.: Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004, 10:1384–1389.

    Article  PubMed  CAS  Google Scholar 

  31. Shibata R, Sato K, Pimentel DR, et al.: Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK and COX-2-depdendent mechanisms. Nat Med 2005, 11:1096–1103.

    Article  PubMed  CAS  Google Scholar 

  32. Yokota T, Oritani K, Takahashi I, et al.: Adiponectin, a novel member of soluble defense collagens, negatively regulates the growth of myelo-monocytic progenitors and the functions of macrophages. Blood 2000, 96:1723–1732.

    PubMed  CAS  Google Scholar 

  33. Ouchi N, Kihara S, Funahashi T, et al.: Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003, 107:671–674.

    Article  PubMed  CAS  Google Scholar 

  34. Kumada M, Kihara S, Ouchi N, et al.: Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004, 109:2046–2049.

    Article  PubMed  CAS  Google Scholar 

  35. Miyoshi Y, Funahashi T, Kihara S, et al.: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003, 9:5699–5704.

    PubMed  CAS  Google Scholar 

  36. Mantzoros C, Petridou E, Dessypris N, et al.: Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004, 89:1102–1107.

    Article  PubMed  CAS  Google Scholar 

  37. Dal Maso L, Augustin LS, Karalis A, et al.: Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004, 89:1160–1163.

    Article  CAS  Google Scholar 

  38. Petridou E, Mantzoros C, Dessypris N, et al.: Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 2003, 88:993–997.

    Article  PubMed  CAS  Google Scholar 

  39. Goktas S, Yilmaz MI, Caglar K, et al.: Prostate cancer and adiponectin. Urology 2005, 65:1168–1172.

    Article  PubMed  Google Scholar 

  40. Wei EK, Giovannucci E, Fuchs CS, et al.: Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005, 97:1688–1694.

    Article  PubMed  CAS  Google Scholar 

  41. Kondo H, Shimomura I, Matsukawa Y, et al.: Association of adiponectin/ACRP30/AdipoQ mutation with type 2 diabetes mellitus: a candidate gene for the insulin resistance syndrome. Diabetes 2002, 51:2325–2358.

    Article  PubMed  CAS  Google Scholar 

  42. Ohashi K, Ouchi N, Kihara S, et al.: Adiponectin 1164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 2004, 43:1195–1200.

    Article  PubMed  CAS  Google Scholar 

  43. Kishida K, Nagaretani H, Kondo H, et al.: Disturbed secretion of mutant adiponectin associated with the metabolic syndrome. Biochem Biophys Res Commun 2003, 306:286–292.

    Article  PubMed  CAS  Google Scholar 

  44. Kamada Y, Tamura S, Kiso S, et al.: Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003, 125:1796–1807.

    Article  PubMed  CAS  Google Scholar 

  45. Kumada M, Kihara S, Sumitsuji S, et al.: for Osaka CAD Study Group: Association of hypo-adiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85–89.

    Article  PubMed  CAS  Google Scholar 

  46. Zoccali C, Mallamaci F, Tripepi G, et al.: Adiponectin, the most abundant adipocyte-derived protein, is functionally related to metabolic risk factors and predicts cardiovascular outcomes in end stage renal disease. J Am Soc Nephrol 2002, 13:134–141.

    Article  PubMed  CAS  Google Scholar 

  47. Pischon T, Girman CJ, Hotamisligil et al.: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730–1737.

    Article  PubMed  CAS  Google Scholar 

  48. Efstathiou SP, Tsioulos DI, Tsiakou AG, et al.: Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005, 36:1915–1919.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, 2-2, Yamada-oka, Suita, 565-0871, Osaka, Japan

    Tohru Funahashi MD, PhD & Yuji Matsuzawa MD, PhD

Authors
  1. Tohru Funahashi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuji Matsuzawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tohru Funahashi MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Funahashi, T., Matsuzawa, Y. Hypoadiponectinemia: A common basis for diseases associated with overnutrition. Curr Atheroscler Rep 8, 433–438 (2006). https://doi.org/10.1007/s11883-006-0042-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-006-0042-8

Keywords

Search

Navigation